# Coronary Angiography THerapeutic Virtual Reality

> **NCT03490903** · NA · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Virtual Reality
- Atherosclerosis
- Coronary Artery Disease
- Anxiety
- Pain, Acute
- Vasospasm;Peripheral

## Interventions

- **DEVICE:** Virtual Reality
- **DRUG:** Fentanyl Injection
- **DRUG:** Midazolam injection

## Key facts

- **NCT ID:** NCT03490903
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled
- **Last updated:** 2021-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490903, "Coronary Angiography THerapeutic Virtual Reality". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03490903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*